IVAN SCHINDELHOLZ
Inventor
Stats
- 4 US patents issued
- 8 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 4 US Patents Issued
- 8 US Applications Filed
- 14 Total Citation Count
- Sep 10, 2021 Most Recent Filing
- Mar 26, 2014 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
ACTELION PHARMACEUTICALS LTD | 4
2 | 2014
2016 |
IDORSIA PHARMACEUTICALS LTD | 1
| 2015
|
Inventor Addresses
Address | Duration |
---|---|
ALLSCHWIL, CH | May 26, 16 - May 26, 16 |
Allschwil, CH | Feb 25, 16 - Mar 03, 22 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 4 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 4 |
C07D: | HETEROCYCLIC COMPOUNDS | 7 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2022/0064,149 | 2022 | COMBINATIONS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH ACTIVE INGREDIENTS FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES | 2 |
2021/0206,750 | 2021 | CRYSTALLINE FORMS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE APROCITENTAN | 3 |
10919881 | 2021 | Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan | 6 |
2020/0061,061 | 2020 | COMBINATIONS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH ACTIVE INGREDIENTS FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES | 2 |
2020/0002,317 | 2020 | CRYSTALLINE FORMS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE APROCITENTAN | 3 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.